In accordance with tumor tissues, the ratio of CD8+CD161+ memory T cells vs CD8+CD161+ memory T cells showed dramatic reduction in blood samples collected in HCC cases (Fig. 5g). This evidence concerns the gene CD8A and hepatocellular carcinoma.